• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Letter to the Editor
MAFLD-related hepatocellular carcinoma in China: An increasing problem
Xiangyu Wu1,2,3, Wenjing Ni1,2,3, Qianqian Chen1,2,3, Junping Shi4, Jie Li1,2,3
1Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
2Department of Infectious Disease, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China
3Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, China
4Department of Infectious Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang, China
Correspondence :  Junping Shi ,
Email: 20131004@hznu.edu.cn
Jie Li ,
Email: lijier@nju.edu.cn
Received: May 22, 2024  Revised: June 4, 2024   Accepted: June 17, 2024
*Xiangyu Wu and Wenjing Ni contributed equally to this work.
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 147 View
  • 13 Download
Related articles

Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis

The clinical management of hepatocellular carcinoma in China: Progress and challenges2023 April;29(2)

Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences2023 April;29(2)

The prime time for management of hepatocellular carcinoma in Hong Kong2023 April;29(2)

Surveillance for hepatocellular carcinoma: It is time to move forward2022 October;28(4)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1462
TOTAL : 1903404
Close layer